Adia Nutrition, a publicly traded company, has opened a Florida clinic, Adia Med, offering stem cell treatments using ethically sourced umbilical cord stem cells.
This clinic aims to provide convenient and FDA-compliant stem cell therapies, comparable to international clinics, for various conditions.
The company highlights the quality of its stem cells, the convenience of a domestic location, and its adherence to U.S. regulations.
Adia Med’s treatments address inflammation, autoimmune disorders, and orthopedic issues, capitalizing on the growing $15.1 billion global stem cell market.
The company emphasizes the ongoing research nature of stem cell therapy and its varied effectiveness.
More info in our latest podcast episode. Take a listen…
